Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial.
Abbass S, Kamal E, Salama M, Salman T, Sabry A, Abdel-Razek W, Helmy S, Abdelgwad A, Sakr N, Elgazzar M, Einar M, Farouk M, Saif M, Shehab I, El-Hosieny E, Mansour M, Mahdi D, Tharwa ES, Salah M, Elrouby O, Waked I.
Abbass S, et al. Among authors: salman t.
J Med Virol. 2021 Dec;93(12):6750-6759. doi: 10.1002/jmv.27264. Epub 2021 Aug 24.
J Med Virol. 2021.
PMID: 34379337
Free PMC article.
Clinical Trial.